Kaiser Permanente-Northwest Region

Portland, Oregon 97227

0 studies enrolling now · 11 studies all time

What they study most

Breast Neoplasms, Early Breast Cancer, HIV Infections, Leukemia, Myeloid, Chronic Phase, Lung Cancer - Non Small Cell Squamous, Myelodysplastic Syndromes, Neoplasm Recurrence, Local, Non Small Cell Lung Carcinoma, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms

Studies at this site

• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2) — Completed
• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin — Completed
• Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality — Completed
• Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes — Completed
• TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer — Completed
• Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) — Stopped early
• A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen — Completed
• A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed